Brief: Deciphera Pharmaceuticals Q3 Basic EPS USD -0.58
30/10/2023 11:01
Oct 30 (Reuters) - Deciphera Pharmaceuticals Q3 operating income USD -53.688 million. * Q3 operating expenses USD 97.001 million * Q3 product revenues USD 41.82 million * Q3 net income USD -49.581 million
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions